IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (Ritedose Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE drug offered from Ritedose Pharmaceuticals, LLC. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ritedose Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | Ipratropium Bromide and Albuterol Sulfate |
| SUBSTANCE NAME: | IPRATROPIUM BROMIDE; ALBUTEROL SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-10-15 |
| END MARKETING DATE: | 0000-00-00 |
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE HUMAN PRESCRIPTION DRUG Details:
| Item Description | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE from Ritedose Pharmaceuticals, LLC |
| LABELER NAME: | Ritedose Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .5; 2.5(mg/3mL; mg/3mL) |
| START MARKETING DATE: | 2012-10-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76204-600_1f78f136-221e-057e-e054-00144ff88e88 |
| PRODUCT NDC: | 76204-600 |
| APPLICATION NUMBER: | ANDA202496 |
Other IPRATROPIUM BROMIDE; ALBUTEROL SULFATE Pharmaceutical Manufacturers / Labelers:
